DAWN DOLAN: Open Payments
NPI 1871549048 · AMHERST, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$950 in 49 payments from 15 companies in 2025. Trend: 2023 $990 · 2024 $566 · 2025 $950
Food & beverage: $950
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $159 |
| Exact Sciences Corporation | 9 | $146 |
| Lilly USA, LLC | 13 | $136 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $121 |
| Teva Pharmaceuticals USA, Inc. | 1 | $109 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $60 |
| PFIZER INC. | 3 | $48 |
| Regeneron Healthcare Solutions, Inc. | 2 | $42 |
| Seqirus USA Inc | 2 | $33 |
| E.R. Squibb & Sons, L.L.C. | 1 | $17 |
Products named: Ozempic, ENTYVIO, The Cologuard Plus Collection Kit, MOUNJARO, XIFAXAN, JARDIANCE, Cologuard Collection Kit, DUPIXENT.
Industry payments across NY — which companies pay providers there.
